Did You Know...
...that Kleenex tissue was originally designed to be a gas mask filter? It was developed at the beginning of World War I to replace cotton, which was then in short supply as a surgical dressing.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8158403 | Enhancer of proliferation of lactic acid bacterium, and agent for improvement in survivability of lactic acid bacterium A dead cell of a lactic acid bacterium or a culture containing the dead cell of a lactic acid bacterium is added to the dairy products such as yogurt, cheese, milk beverage or the like in an amount of 0.001 wt % or more in dry weight of the dead cell, therefore, it ... | 04/17/2012 |
| 8137952 | Thermostable lactobacillus strains The present invention relates to the Lactobacillus genus that have the ability to survive in high temperature environments. These thermostable microorganisms have the ability to produce viable antibacterial agents in different food products after heat 5 treat... | 03/20/2012 |
| 8114658 | Method of moisturizing skin The present invention provides a moisturizer comprising heat-killed cells of Lactobacillus plantarum as an active ingredient. The moisturizer of the present invention improves the water retention capacity of the stratum corneum, and is useful for prevention a... | 02/14/2012 |
| 8043843 | Metabolically engineered lactic acid bacteria and their use Mutants of lactic acid bacteria including Lactococcus lactis which are defective in pyruvate formate-lyase production and/or in their lactate dehydrogenase (Ldh) production and methods of isolating such mutants or variants are provided. The mutants are useful... | 10/25/2011 |
| 8034606 | Acid tolerant probio-65 with the ability of growth suppression of pathogenic microorganisms and the anti-allergic effect Disclosed are a novel tactic acid bacterium, Lactobacillus sakei Probio-65, and the use thereof. The L. sakei Probio-65 strain has acid tolerance, bile acid tolerance and antibiotic resistance, inhibits the growth of harmful pathogenic microorganisms i... | 10/11/2011 |
| 8021868 | Anti-allergy lactic acid bacteria The invention described relates to novel strains of lactic acid bacteria and their use in anti-allergy. The composition may be in the form of foodstuffs or in the form of pharmaceutical compositions. ... | 09/20/2011 |
| 7955834 | Method for improved breast milk feeding to reduce the risk of allergy Selected strains of Lactobacillus and products containing cells of the selected strains to improve breast milk for feeding to babies, more precisely to increase the levels of the anti-inflammatory cytokine IL10 in the milk and reduce the risk that the feeding... | 06/07/2011 |
| 7901925 | ssp. strain and compositions A novel strain of Lactobacillus delbrueckii, ssp. bulgaricus, including probiotic compositions comprising the bacteria, and methods for using the bacteria and/or the compositions for treatments of diseased states and boosting immune response. ... | 03/08/2011 |
| 7901926 | isolates having anti-inflammatory activities and uses of the same Disclosed herein are two Lactobacillus isolates having anti-inflammatory activities and beneficial probiotic properties, i.e., Lactobacillus sakei GMNL-76 and Lactobacillus reuteri GMNL-89, which were deposited in the Biosource Collection and Re... | 03/08/2011 |
| 7897374 | Human ABO blood group-binding lactobacilli Lactobacillus screening methods were carried out using surface plasmon resonance spectrums and human intestinal mucin and blood group antigens as probes. A trial to set selection criteria in the above-mentioned methods of screening for lactobacilli was made t... | 03/01/2011 |
| 7863033 | Lactobacillus living body activating Lactobacillus preparation and preventive or therapeutic agent for living body infection There has been effort to develop a lactobacillus that would be useful as a probiotic, and to develop a lactobacillus which would colonize and proliferate in lesions of infection, eliminating the causal bacteria. This problem was resolved by developing a La... | 01/04/2011 |
| 7846711 | strains and uses thereof The invention concerns new isolated Lactobacillus cells, which are capable to aggregate Helicobacter pylori under culture conditions of the human digestive tract, in particular of the stomach, and to the uses of such cells. ... | 12/07/2010 |
| 7842495 | Lactic acid bacteria capable of stimulating mucosal immunity The invention provides lactic acid bacteria selected from the group consisting of lactobacillus ONRIC b0239 (FERM BP-10064) and lactobacillus ONRIC b0240 (FERM BP-10065), and compositions containing the bacteria, the compositions being capable of stimu... | 11/30/2010 |
| 7799551 | Ferulate esterase producing strains and methods of using same Ferulate esterase producing bacterial strains or functional mutants thereof and methods of using ferulate esterase producing bacterial strains as forage additives are disclosed. ... | 09/21/2010 |
| 7771982 | Probiotics for pet food applications The present invention relates to novel lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions intended to improve the health of pets, and to compositions cont... | 08/10/2010 |
| 7759108 | Method for producing fermented milk containing angiotensin converting enzyme inhibitory peptide and method for producing whey There are disclosed methods for producing fermented milk and whey that enable effective production in high yield of fermented milk and whey having high content of an ACEI peptide that is highly safe and applicable to pharmaceuticals, functional foods, health foods, ... | 07/20/2010 |
| 7674613 | Live bacterium preparation containing lactic acid bacterium as active ingredient and food containing lactic acid bacterium Disclosed is a live bacterium preparation or food containing a lactic acid bacterium comprising a lactic acid bacterium, Lactobacillus salivarius, as an active ingredient. There is provided a live bacterium preparation and food containing a lactic acid bacter... | 03/09/2010 |
| 7625745 | Alcohol-tolerant malolactic strains for the maturation of wines with average or high pH Lactic bacterial strains of the genera Lactobacillus and Pediococcus which are capable of initiating and carrying out a complete malolactic fermentation on direct introduction, in the dried, frozen or lyophilised state, without a previous acclimatizati... | 12/01/2009 |
| 7550285 | Endotoxin binding lactic acid bacteria and bifidobacteria The invention relates to the use of at least one strain of lactic acid bacteria and/or bifidobacteria having hydrophobic surface properties, for the preparation of a composition intended for the prevention or the treatment of endotoxin mediated and/or associated dis... | 06/23/2009 |
| 7537925 | Mutated strain A mutant of Lactococcus lactis spp. lactis, which produces lactate at high volumetric and specific productivity as well as high amounts of lactate dehydrogenase, as well as the use of said strain, and a method for producing lactate, as well as the use ... | 05/26/2009 |
| 7517681 | Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries New strains of Lactobacillus that have been selected for their capability of improved reduction the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with better binding to the oral mucins and dental plaq... | 04/14/2009 |
| 7507572 | Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains The invention refers to a composition comprising one or more tannase-producing strains of Lactobacillus having the ability to adhere to the human intestinal mucosa in combination with tannin. New tannase-producing strains of Lactobacillus plantarum are... | 03/24/2009 |
| 7501274 | Lactic acid bacteria with immunoregulating activities The invention provides novel lactic acid bacteria having immunoregulating activities and usable in food and drinks, medicaments, and other applications. Specifically, the invention provides novel lactic acid bacteria separated from “Shibazuke,” one kind of tradi... | 03/10/2009 |
| 7468270 | Probiotic strains, a process for the selection of them, compositions thereof, and their use The present invention relates to a novel process for the selection of new probiotic strains which comprises the following steps: a) selecting for non-pathogenic strains which are capable of surviving in breast milk and/or amniotic fluid, and b) selecting for non-pat... | 12/23/2008 |
| 7465575 | Metabolically engineered lactic acid bacteria and their use Mutants of lactic acid bacteria including Lactococcus lactis which are defective in pyruvate formate-lyase production and/or in their lactate dehydrogenase (Ldh) production and methods of isolating such mutants or variants are provided. The mutants are useful... | 12/16/2008 |
| 7465576 | Method for treating periodontal disease with a bacteriocidal disinfectant A method for treating periodontal disease by first disinfecting the affected part with a bactericidal disinfectant containing ferric ions (Fe+3) and L-ascorbic acid as the principal components and one or more of sorbic acid, benzoic acid and para-hydroxyb... | 12/16/2008 |
| 7435574 | NADH oxidase from The present invention is directed to a new NADH oxidase from Lactobacillus, nucleic acids encoding the NADH oxidase, methods of producing the NADH oxidase, as well as there use in producing improved NADH oxidase enzymes and for producing chrial enantiomer-enr... | 10/14/2008 |
| 7427398 | Mammalian animal composition The present invention relates to the use of probiotic microorganism in the manufacture of a composition for the prevention or reduction of gastrointestinal Campylobacter infection in a mammalian animal. It also relates to a method for the prevention or reduct... | 09/23/2008 |
| 7390519 | Probiotic strains A Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable gastrointestinal inflammatory activity, such as inflammatory b... | 06/24/2008 |
| 7384628 | Lactic acid bacteria and its use in direct-fed microbials A composition comprising lactic acid bacteria that are selected from at least one of Lactococcus lactis, Lactobacillus lactis, and Lactobacillus brevis. The composition is suitable for administration to animals. Upon administration to an animal, the co... | 06/10/2008 |
| 7381406 | Probiotic strains for pets The present invention provides novel strains of probiotics for use in the gastrointestinal tract of a pet. The probiotics of the present invention are capable of fermenting starch to produce lactic acid and/or hydrogen peroxide anti-pathogenic metabolites. The prese... | 06/03/2008 |
| 7374924 | Use of selected lactic acid bacteria for reducing infantile colic The invention herein provides certain strains of lactic acid bacteria selected for their capability of promoting production of IL-10 and consequently proliferation of CD4+CD25+ TR cells, for prophylaxis and/or treatment of infant colic, a method of selecting such st... | 05/20/2008 |
| 7358083 | Food-grade cloning vector and their use in lactic acid bacteria Novel food-grade cloning vectors comprising a nonsense mutation suppressor-encoding gene, which vector, when it is present in a lactic acid bacterial strain, permits such a strain to have an industrially appropriate growth rate and metabolic activity. The cloning ve... | 04/15/2008 |
| 7354757 | strain Lactobacillus strains that have a genetic Profile I based on Apa I, Not I, and Xba I digests are provided. Preferably, the strains decrease level of at least one of coliforms and E. coli within the gastrointestinal tract of an animal. A direct-fed micr... | 04/08/2008 |
| 7351572 | Microorganism strain GM-090 of and its use for stimulating IFN-γ secretion and/or treating allergy The present invention provides an isolated microorganism strain, Lactobacillus fermentum GM-090, which is found to be effective in stimulating IFN-γ secretion and/or treating allergy. The use of the Lactobacillus fermentum GM-090 in stimulating IFN-γ... | 04/01/2008 |
| 7329741 | Polynucleotides that hybridize to DP-75 and their use The present invention is a novel nucleic acid sequence which hybridizes to SEQ ID NO:6 or fragments thereof under stringent conditions, or fragments thereof. The invention also includes diagnostic assays, expression vectors, control sequences, antisense molecules, r... | 02/12/2008 |
| 7326558 | Process for treating spirulina The treatment of spirulina by a process which includes placing spirulina that has not been previously heat-sterilized, lactic acid bacteria and sugar in water, then culturing the lactic acid bacteria provides treated spirulina in which the distinctive taste and odor... | 02/05/2008 |
| RE40023 | Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use A pharmaceutical composition containing several different bacteria including Streptococcus thermophilus, Lactobacilli and Bifidobacteria is disclosed. The bacteria are present in the composition at a total concentration of 1×1011 to 1×1013 pe... | 01/22/2008 |
| 7312067 | Lactic acid producing bacteria for use as probiotic organisms in the human vagina The present invention discloses novel isolated strains of lactic acid producing bacteria of the genera Lactobacillus and Pediococcus, and a method for isolation of such bacterial strains, having the ability to colonise and become established in a human... | 12/25/2007 |
| 7300787 | strains and use thereof in fermentation for L-lactic acid production The present invention relates to L-lactic acid producing bacterial strains, including Lactobacilli such as NRRL B-30568 (ADM B64), NRRL B-30569 (ADM DEC2-2B), NRRL B-30570 (ADM RP1A-4E), NRRL B-30571 (ADM RP2-1C), NRRL B-30572 (ADM RP3-1E), NRRL, B-30573 (ADM... | 11/27/2007 |
